Microbiology

  1. Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro

    1. Nicola Clementi
    2. Elena Criscuolo
    3. Roberta Antonia Diotti
    4. Roberto Ferrarese
    5. Matteo Castelli
    6. Lorenzo Dagna
    7. Roberto Burioni
    8. Massimo Clementi
    9. Nicasio Mancini

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV

    1. Aleksandra Milewska
    2. Ying Chi
    3. Artur Szczepanski
    4. Emilia Barreto-Duran
    5. Kevin Liu
    6. Dan Liu
    7. Xiling Guo
    8. Yiyue Ge
    9. Jingxin Li
    10. Lunbiao Cui
    11. Marek Ochman
    12. Maciej Urlik
    13. Sylwia Rodziewicz-Motowidlo
    14. Fengcai Zhu
    15. Krzysztof Szczubialka
    16. Maria Nowakowska
    17. Krzysztof Pyrc

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Orthogonal genome-wide screens of bat cells identify MTHFD1 as a target of broad antiviral therapy

    1. Danielle E. Anderson
    2. Jin Cui
    3. Qian Ye
    4. Baoying Huang
    5. Ya Tan
    6. Chao Jiang
    7. Wenhong Zu
    8. Jing Gong
    9. Weiqiang Liu
    10. So Young Kim
    11. Biao Guo Yan
    12. Kristmundur Sigmundsson
    13. Xiao Fang Lim
    14. Fei Ye
    15. Peihua Niu
    16. Aaron T. Irving
    17. Haoyu Zhang
    18. Yefeng Tang
    19. Xuming Zhou
    20. Yu Wang
    21. Wenjie Tan
    22. Lin-Fa Wang
    23. Xu Tan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution

    1. Roshan Kumar
    2. Helianthous Verma
    3. Nirjara Singhvi
    4. Utkarsh Sood
    5. Vipin Gupta
    6. Mona Singh
    7. Rashmi Kumari
    8. Princy Hira
    9. Shekhar Nagar
    10. Chandni Talwar
    11. Namita Nayyar
    12. Shailly Anand
    13. Charu Dogra Rawat
    14. Mansi Verma
    15. Ram Krishan Negi
    16. Yogendra Singh
    17. Rup Lal

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Site-specific glycan analysis of the SARS-CoV-2 spike

    1. Yasunori Watanabe
    2. Joel D. Allen
    3. Daniel Wrapp
    4. Jason S. McLellan
    5. Max Crispin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity

    1. Yuanmei Zhu
    2. Danwei Yu
    3. Hongxia Yan
    4. Huihui Chong
    5. Yuxian He

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

    1. Daniel Wrapp
    2. Dorien De Vlieger
    3. Kizzmekia S. Corbett
    4. Gretel M. Torres
    5. Nianshuang Wang
    6. Wander Van Breedam
    7. Kenny Roose
    8. Loes van Schie
    9. Markus Hoffmann
    10. Stefan Pöhlmann
    11. Barney S. Graham
    12. Nico Callewaert
    13. Bert Schepens
    14. Xavier Saelens
    15. Jason S. McLellan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Topoisomerase III-β is required for efficient replication of positive-sense RNA viruses

    1. K. Reddisiva Prasanth
    2. Minato Hirano
    3. W. Samuel Fagg
    4. Eileen T. McAnarney
    5. Chao Shan
    6. Xuping Xie
    7. Adam Hage
    8. Colette A. Pietzsch
    9. Alexander Bukreyev
    10. Ricardo Rajsbaum
    11. Pei-Yong Shi
    12. Mark T. Bedford
    13. Shelton S. Bradrick
    14. Vineet Menachery
    15. Mariano A. Garcia-Blanco

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo

    1. Stuart Weston
    2. Christopher M. Coleman
    3. Rob Haupt
    4. James Logue
    5. Krystal Matthews
    6. Matthew B. Frieman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

    1. Daniel Blanco-Melo
    2. Benjamin E. Nilsson-Payant
    3. Wen-Chun Liu
    4. Skyler Uhl
    5. Daisy Hoagland
    6. Rasmus Møller
    7. Tristan X. Jordan
    8. Kohei Oishi
    9. Maryline Panis
    10. David Sachs
    11. Taia T. Wang
    12. Robert E. Schwartz
    13. Jean K. Lim
    14. Randy A. Albrecht
    15. Benjamin R. tenOever

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 72 of 249 Next